Home›Stock Screener›Choksi Laboratories›Financial Statements

Choksi Laboratories Complete Financial Statements

11 Years of Data
2025 - 2015

In FYNone, Choksi Laboratories (CHOKSILA) reported revenue ₹46 Cr, net profit ₹2 Cr and EPS ₹2.70, with a net profit margin of 4.8% and ROE of 8.3%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review CHOKSILA P/E ratio to evaluate earnings-based valuation against sector peers.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 4.76% 2025 data
EBITDA Margin 26.19% 2025 data
Operating Margin 27.00% 2025 data
Return on Assets 3.08% 2025 data
Return on Equity 8.33% 2025 data

Balance Sheet Ratios

Current Ratio 0.89 2025 data
Equity Ratio 36.92% 2025 data
Asset Turnover 0.65 2025 data

CHOKSILA Revenue, Net Profit & EBITDA — Year-on-Year Growth

CHOKSILA YoY (March 2025 vs Period) — revenue +9.5%, EBITDA +18.2%, expenses +6.5%. Explore Choksi Laboratories intrinsic worth to estimate fundamental worth using multiple valuation models.

Revenue Growth
+9.5%
Year-over-Year
EBITDA Growth
+18.2%
Year-over-Year
Expense Growth
+6.5%
Year-over-Year
Assets Growth
+4.8%
Year-over-Year
Equity Growth
+9.1%
Year-over-Year
Investing Cash Flow Growth
-14.3%
Year-over-Year
Financing Cash Flow Growth
+20.0%
Year-over-Year

CHOKSILA Income Statement — Revenue, EBITDA & Net Profit

Choksi Laboratories revenue ₹46 Cr, EBITDA ₹13 Cr, net profit ₹2 Cr, EPS ₹2.70 (None) — net profit margin 4.8%. For live price, earnings ratios and company overview, see CHOKSILA share price.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 46 42 37 35 30 26 29 34 31 30 22 23
Expenses 33 31 27 24 21 22 25 27 24 24 17 17
EBITDA 13 11 10 11 9 5 3 8 7 6 5 6
Operating Profit Margin % 27.00% 27.00% 28.00% 30.00% 30.00% 16.00% 10.00% 22.00% 21.00% 17.00% 23.00% 23.00%
Depreciation 7 7 6 6 5 5 5 4 3 3 3 3
Interest 3 3 3 4 3 3 2 2 2 2 1 2
Profit Before Tax 3 2 2 4 0 -3 -6 2 2 1 1 1
Tax 1 1 1 1 0 0 -2 1 1 0 0 1
Net Profit 2 2 1 3 0 -3 -4 2 1 1 1 1
Earnings Per Share (₹) 2.70 2.19 1.59 4.61 0.30 -3.74 -5.58 2.30 1.93 1.28 1.04 1.27

CHOKSILA Balance Sheet — Assets, Liabilities & Shareholders' Equity

CHOKSILA total assets ₹65 Cr, total equity ₹24 Cr, total liabilities ₹ Cr (2025) — ROE 8.3%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 65 62 60 64 66 65 55 45 41 43 38
Current Assets 16 15 14 14 13 17 16 15 13 15 15
Fixed Assets 48 43 45 47 50 33 35 29 22 18 19
Capital Work in Progress 0 3 0 2 1 13 3 0 4 9 3
Investments 0 0 0 0 0 0 0 0 0 0 0
Other Assets 18 16 15 16 16 19 17 16 14 16 16
LIABILITIES
Total Liabilities
Current Liabilities 18 21 27 31 32 30 18 7 5 9 7
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 24 22 21 18 18 20 24 22 21 20 19
Share Capital 7 7 7 7 7 7 7 7 7 7 7
Reserves & Surplus 17 15 14 11 11 13 17 15 14 13 12

CHOKSILA Cash Flow Statement — Operating, Investing & Financing

Choksi Laboratories operating cash flow ₹12 Cr, investing ₹-8 Cr, financing ₹-4 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 12 12 8 8 6 3 7 6 7 0 2
Investing Activities -8 -7 -1 -3 -8 -14 -10 -5 -2 0 -1
Financing Activities -4 -5 -8 -5 2 11 2 -1 -5 0 -1
Net Cash Flow 0 0 0 0 0 0 -1 0 0 0 0